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Background: While asthma is known to be associated with cardiovascular disease (CVD), the
relation to specific manifestations of CVD has not been previously described. Our objective
was to explore the relation of child and adult-onset asthma with specific CVD conditions.
Methods: We examined data from 16,943 (projected 178 million) U.S. adults aged 18e90 years
old with relevant information on asthma and CVD. The study was a cross-sectional analysis of
the National Health and Nutrition Examination Survey 1999e2006. We determined the preva-
lence of CVD risk factors and likelihood of CVD conditions according to gender and asthma
status using multiple logistic regression adjusted for age, gender and other CVD risk factors.
Results: The proportions of subjects with child and adult-onset asthma were 4.8% (nZ 702)
and 3.3% (nZ 534), respectively. Adult-onset asthma was significantly associated with total
CVD (ORZ 2.07, CIZ 1.2e3.7), but child-onset asthma was not associated with any CVD condi-
tions. Of the four specific CVD endpoints, adult-onset asthma overall was only associated with
coronary heart disease (CHD) (ORZ 2.26, CIZ 1.2e4.2) in the total population.
Conclusions: Our data suggests that CHD is the major cardiovascular condition associated with
asthma; a prospective study must be done to confirm a causal relationship.
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Asthma is a chronic inflammatory process in the airway
characterized by bronchospasms and airflow obstruction
and affects an estimated 300 million people worldwide.
Adults with asthma or asthmatic symptoms have been
shown to have higher levels of C-reactive protein (Hs-CRP),4
a known inflammatory marker and risk factor for cardio-
vascular disease (CVD). Inflammation has been considered.
Asthma association with cardiovascular conditions 949to have a significant role in pathogenesis of athe-
rosclerosis,1e3 but despite many studies examining the
association of impaired lung function and CVD5e16 there
were relatively few publications to relate asthma to CVD.
However, in recent years, several studies support the
association of asthma and CVD.17e23 A prospective study of
15,792 adults in 2008 by Onufrak showed a 2-fold increase
in the risk of stroke and coronary heart disease (CHD), while
a Canadian study determined people with asthma were at
increased odds of heart disease when compared to people
without asthma.18 In a retrospective study of a large
insurance cohort in 2004, Iribarren et al. reported multi-
variate adjusted HRs of 1.22 in women with asthma19 with
CHD as the endpoint. Although all the papers support the
association of asthma and CVD, they all relate different
specific CVD endpoints to asthma: stroke, CHD and hyper-
tension, sometimes with different results for the same
condition. A study by Dogra found no correlation between
stroke and asthma, while an Onufrak study found that there
was a stroke correlation. Even though asthma has been
shown to be associated with CVD, the relation to specific
manifestations of CVD, such as myocardial infarction,
stroke, heart failure or angina, varies from paper to paper
and has not been described in depth. In this paper we
examined in a population-representative sample of U.S.
adults the relation of child-onset and adult-onset asthma
with specific CVD conditions in order to clarify which
conditions form the association. We also examined whether
levels of inflammation measured by C-reactive protein
influenced the relation of asthma with CVD.Methods
The 1999e2006 U.S. National Health and Nutrition Survey
(termed NHANES IV) is a cross-sectional study providing
information on more than 16,000 adults with asthma, CVD
and other relevant cardiovascular information.24 The data
from NHANES were self-reported (physician diagnosis, age
when first diagnosed, current asthma status) for asthma,
CVD risk factors, and demographic information. We exam-
ined data taken from adults ages 18 and above (nZ 16,943
weighted to U.S. population, 51.7% female). 18 persons
with missing asthma data were excluded from the study.
The asthma variable was also created from self-reported
data because NHANES IV (1999e2006) specifically does not
provide spirometric data or any form of quantitative lung
function testing.
People designated as adult-onset asthma had to be 18 or
older and have been diagnosed with asthma at the age of 18
or greater. Anyone who had been diagnosed with asthma
below the age of 18 was labeled child-onset asthma, and all
others were set as no asthma.
The four endpoints used for the analysis were stroke,
congestive heart failure (CHF), coronary heart disease
(CHD), and total CVD. Total CVD was defined by a doctor
telling the subject that they had one of the following
conditions 1) myocardial infarction, 2) stroke, 3) angina, 4)
congestive heart failure (CHF), or 5) CHD. CHD was defined
as having either having angina, a myocardial infarction, or
the direct label of CHD. C-reactive protein (Hs-CRP) levels
were categorized as either above (high) or below or equalto (low) 3 mg/L.25 Diabetes was defined as having either
a glucose level of 126 mg/dl26 or higher with a fasting time
greater than 12 h, being told that by a doctor that the
subject has diabetes, or if the subject is taking insulin or
diabetic pills. Smoking was defined as currently smoking or
not. Body mass index (BMI) was categorized into three
groups: BMI< 25, BMI greater than 25 and less than 30, and
BMI 30.
A Chi-squared test of proportions was used to find the
proportions of asthma, CVD, diabetes and other risk factors
within the subject population. The population itself was
divided and categorized by gender across asthma status.
Variables such as age, systolic blood pressure and choles-
terol were continuous variables, and their means and
standard deviations were determined. Multiple logistic
regression was used to calculate the odds of CVD and
specific CVD conditions according to asthma status,
adjusted for other CVD risk factors (age, systolic blood
pressure, HDL cholesterol, BMI, Hs-CRP, smoking, and dia-
betes mellitus). The logistic regressions were done using
those without asthma as the reference. Another logistic
regression was done to test for an interaction between
asthma status and Hs-CRP. Multiple logistic regressions
were also done with each of the specific CVD conditions as
the endpoint.Results
Females made up 52% (nZ 8761) of the total subject
sample (nZ 16,943), and had twice the prevalence of
males affected with adult-onset asthma (4.5% vs. 2.1%).
The proportions of child and adult-onset asthma were 4.8%
(nZ 702) and 3.3% (nZ 534) respectively. People with
child-onset asthma tended to be the youngest (37.7 16.0
years) and have a higher proportion of smoking (26.3%).
Table 1 shows the proportions or means of CVD risk factors
across the total population. The table also shows the
prevalence of the four CVD conditions for all asthma
groups: stroke, CHF, CHD, and CVD. Table 2 displays the
prevalence of the four conditions across asthma status.
Within the overall population, the prevalence of all CVD
conditions was highest in people with adult-onset asthma
and lowest in persons with child-onset asthma, with the
exception of CHF. People with adult-onset asthma tended
to be older (53.1 18.4 years), more likely to be over-
weight (44%) and diabetic (9.8%)and had higher HDL-
cholesterol (56.0 16.3 mg/dL) levels than the other
groups. Men and women with adult-onset asthma had
a similar prevalence of obesity (43.8% vs. 44.4%) and
women with asthma had a substantially higher Hs-CRP level
(6.0 vs. 4.6 mg/L). The ratio of women with adult-onset
asthma to men was 2:1, while the proportions of other
conditions such as total CVD and CHD were equal across
gender in people with adult-onset asthma.
Table 2 shows the odds ratios for specific CVD conditions
in various populations split by asthma status and gender.
The columns show the odds ratios for each of the CVD
endpoints in an asthmatic group, further divided among
males, females, and overall. Adult-onset asthma was found
to have a significant association with total CVD (ORZ 2.1,
CIZ 1.2e3.7). Only one specific cardiovascular condition
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950 H.M. Lee et al.was significantly associated with adult-onset asthma:CHD
(ORZ 2.3, CIZ 1.2e4.2). Child-onset asthma showed no
association with any of the CVD conditions. When males
with adult-onset asthma were isolated, all the resulting
odds ratios were insignificant. In gender stratified analyses,
only females with adult-onset asthma showed an increase
in the odds for total CVD (ORZ 2.4, CIZ 1.2e4.7) and CHD
(ORZ 2.9, CIZ 1.4e6.3).
A logistic regression of CRP and asthma status showed
that both males and females with adult-onset asthma and
females with child-onset asthma had higher Hs-CRP levels
when compared to those with no asthma (5.6 and 6.0 vs.
4.8 mg/L). A separate multiple logistic regression adjusting
for all risk factors showed Hs-CRP was significantly associ-
ated with total CVD (ORZ 1.5, CIZ 1.1e2.0) and CHF
(ORZ 1.8, CIZ 1.1e2.8). However, an analysis using an
interaction term of asthma status and Hs-CRP testing with
an endpoint of CVD did not show any significant relation
between asthma status and Hs-CRP levels. A further logistic
regression was done examining asthma status with CVD
when differed by gender-BMI groups. We found only
females with adult-onset asthma and a BMI greater than 25
and less than 30 had a greater likelihood of CVD (OR: 6.5,
CIZ 2.2e19.0) compared to people with no asthma.
Discussion
Our study suggests that only individuals with adult-onset
asthma had an increased likelihood for CHD and total CVD
when compared to those with no asthma, and that CHD is
the major manifestation of CVD related to adult-onset
asthma. Women with adult-onset asthma appeared more
likely to have CVD than men with adult-onset asthma. The
findings for total CVD were consistent with previous stud-
ies,17e23 but when comparing the specific CVD endpoints of
each paper, there is less consistency in these results. The
study by Onufrak found that women with adult-onset
asthma had an increased risk of both CHD and stroke,
while the Atherosclerosis Risk in Communities (ARIC) study
showed that compared to individuals without asthma, those
with asthma did not have a higher relative risk (RR) of CHD.
On the other hand, the same study found those individuals
with asthma did have an increased RR of stroke.20 This was
the first study to focus on the association of specific CVD
conditions with adult-onset asthma and warrants a deeper
investigation as to why CHD is the CVD manifestation most
associated with asthma.
Because of the chronic inflammatory nature of asthma,
inflammatory markers were included in previous studies,
but only the two ARIC studies17,20 included fibrinogen as an
inflammatory marker, and no studies included Hs-CRP as an
inflammatory marker. Since inflammation is also a major
factor in CHD, it was important to consider Hs-CRP as
a potential link between the CHD and asthma. Hs-CRP was
not shown to have any interaction with asthma status, but
nonetheless both asthma and Hs-CRP were independently
associated with CHD and CVD, which supports previous
studies. Since asthma patients are usually treated with
corticosteroids to treat their airway inflammation, it would
be appropriate to analyze the effects of steroids as the
potential connection between asthma and CHD. Since
patients with both child-onset and adult-onset asthma use
Table 2 Risk factor adjusted odds for specific conditions of CVD by asthma status (nZ 16,943).
OR (95% CI) Adult onset Child onset
Overall Male Female Overall Male Female
Stroke 2.09(0.94e4.67) 1.66(0.49e5.60) 2.06(0.75e5.67) 1.00(0.28e3.60) 1.29(0.25e6.65) 0.52(0.07e4.19)
Congestive Heart
Failure
1.46(0.58e3.66) 1.69(0.42e6.89) 1.29(0.36e4.63) 0.88(0.27e2.88) 0.42(0.11e1.58) 1.72(0.42e7.03)
Coronary Heart
Disease
2.26(1.23e4.17) 1.18(0.42e3.31) 2.94**(1.37e6.33) 0.55(0.24e1.26) 0.39 (0.16e0.99) 0.75(0.19e2.97)
Total CVD 2.07(1.17e3.66) 1.31(0.52e3.28) 2.37*(1.18e4.74) 0.64(0.30e1.33) 0.57(0.22e1.49) 0.63(0.20e4.74)
Reference group is no asthma; estimates adjusted for age, systolic blood pressure, HDL cholesterol, BMI, Hs-CRP, smoking, and diabetes
mellitus.
Asthma association with cardiovascular conditions 951these medicines, steroids would not fully explain why child-
onset asthma was never found to be significantly associated
with CVD. The fact that people with adult-onset asthma
were much older than those with child-onset asthma may
have contributed to the analysis results due to the fact that
age is correlated with CVD risk. A possible explanation for
the lack of an association between CVD and child-onset
asthma is that child-onset asthma stems from an allergic
basis in contrast to adult-onset asthma which has been
related to environmental irritants and gender. These
factors may contribute to an increase in CVD as a conse-
quence of irritants and hormones. Adult-onset asthma
differs from child-onset asthma because it comes from
more intrinsic causes in the body, such as hormones and
stiffening of chest walls. These factors inside the body can
lead to an increase in CVD risk.
We observed that adult-onset asthma was more preva-
lent in women than in men by a 2:1 ratio. Also the odds of
both CHD and total CVD were nearly double for women
compared to men. It is unclear as to why relationships of
asthma and CVD in women are stronger than that observed
in men. Onufrak et al. suggests that estrogen enhances
proinflammatory cytokines activated from monocytes,
macrophages and vascular cells and also regulates the
production of leukotrienes from mast cells, all of which are
known to stimulate asthma. The incidence rate of asthma
in women correlates with shifts in estrogen levels, with
incidence increasing after puberty and peaking during the
onset of menopause. Authors speculate that women who
develop asthma during these hormonal cycle events may be
particularly susceptible to estrogen-modulated alterations
in inflammatory cytokine and leukotriene regulation.17
To further elucidate possible reasons for the gender
difference relating asthma to CVD, we decided to split the
patients by three criteria: gender (male and female),
asthma status (adult, child-onset and neither) and BMI
(<25, 25e<30 and 30). This new variable was used in
a subgroup analysis to test for the effects of asthma across
BMI-gender groups on CVD morbidity in addition to the
asthma analysis. The result showed that males with asthma
from all BMI groups were not significantly associated with
CVD, but females with adult-onset asthma and a BMI
between 25 and 30 (the intermediate group) had a signifi-
cant association with CVD. This differs from expected
results, where the morbidly obese group with 30þ BMI was
expected to have the strongest relation to CVD. It is
possible that the subject populations had COPD patientsbecause the long-term airway remodeling from the
inflammatory response and subsequent repair in asthmatics
can produce irreversible airway obstruction and contribute
a decline in lung function over time.20,27,28 With this
reduced lung function, CVD risk could have been associated
with asthma5e16; however, there is no good reason to
believe that women with asthma have more association
with CVD when reduced lung function is present. Future
studies could elaborate on the exact mechanisms of asso-
ciation between men with asthma vs. women with asthma
to CVD. These studies could focus on hormonal levels and
other biomarkers, as well as the effects of sleep disorders.
The methodology of our study was similar to that of
Iribarren et al.,19 where the subject population was limited
to those aged 18 and greater in order to focus on adult-
onset asthma. The data collection methods were also
similar to the ARIC study because the asthma was self-
reported and doctor diagnosed. The main difference
between this study and previous projects was the varying
methods of data collection. Some previous clinical studies
have used physician-reported data from specific hospitals.
This study used data from NHANES 1999e2006, where some
of the questions used in formulating variables were self-
reported without physician confirmation, which may not
be valid. Another difference in data collection was the fact
that the data from this study was cross-sectional, while the
data used from other studies mostly consisted of longitu-
dinal data, which is better for predicting the long-term
effects of a disease. In order to discern whether asthma
as whole, not just adult-onset asthma, was associated with
CVD, a child-onset asthma variable was created to cover all
subjects with asthma diagnosed before age 18.
An important strength of our study was the use of the
large NHANES population that enabled us to generalize our
results to free-living adults in the U.S. The survey also
included specific cardiovascular conditions and important
confounding factors, and the detailed information on
asthma subtype within gender allowed for the investigation
of increased CVD odds in females. There were also limita-
tions in the study, the most important being the fact that
the data from NHANES was cross sectional. Since cross-
sectional data are derived from taking a sample at a single
point in time, we could not confirm a definite causal
relation between asthma and CVD. The dataset was not
able to describe the temporal relation between asthma and
CVD, such as identifying which condition the patient was
diagnosed with first. Prospective studies need to be
952 H.M. Lee et al.examined to verify temporality and causality. Most of the
data was patient self-reported and the asthma variable
used in the research did not assess asthma based on
spirometry tests because NHANES IV does not provide such
data. This is considered a limitation because of concerns of
the validity of self-reported asthma data, and the lack of
quantitative spirometric data precluded our ability to
exclude the possibility that COPD, a potential confounder,
may have been present. Another limitation was that the
small number of events, particularly, stroke, caused power
issues that need to be considered in interpretation. The
lack of asthma medication information including dosages
was also a limitation, as use of steroids may have also
confounded results.
The data supports the conclusion that coronary heart
disease is the principal cardiovascular manifestation form-
ing the association of asthma with cardiovascular disease;
however, not established is whether controlling asthma
would actually reduce CHD incidence and further prospec-
tive studies should consider investigating this.Author Disclosure
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